- BlueModus News
- Feb 19, 2020
BlueModus has recently made a $500 donation to the Multidisciplinary Association for Psychedelic Studies (MAPS), as part of its continuing commitment to give back to the community. MAPS is a non-profit research and educational organization that works to develop medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.
Since its founding in 1986, MAPS has furthered its mission through developing psychedelics and marijuana into prescription medicines, educating the public honestly about the risks and benefits of psychedelics and marijuana, and supporting scientific research into the medical benefits of these substances. Currently they are studying whether MDMA-assisted psychotherapy can help heal psychological and emotional damage caused by post-traumatic stress disorder (PTSD), as well as studying MDMA-assisted therapy for autistic adults with social anxiety and for people with anxiety related to life-threatening illnesses, with an ultimate goal of developing MDMA-assisted psychotherapy into a legal, FDA-approved treatment for PTSD.
BlueModus Solution Lead John Fager, who selected this charity, says he has been following the work that MAPS does for quite a while regarding the treatment of mental trauma.
“MAPS is unique in that they are looking to achieve long-term dividends from donations by learning how to treat some very difficult mental health issues,” shares John. “Their work around PTSD treatment is especially important for returning troops. I think the work they are doing is extremely valuable, since this is a largely neglected field and our society is way behind in the science and stigma of mental health.”
If you would like to learn more about MAPS and how you can support their cause, please visit their website at https://maps.org.
2020 marks an expansion of BlueModus’ charitable give-back program: Two colleagues each month will be selecting charitable causes important to them to receive a $500 donation. Click here to read about the other selection made this month.